Clover Health Investments (NASDAQ:CLOV) executives used the company’s fourth-quarter 2025 earnings call to emphasize a combination of profitability and rapid Medicare Advantage membership growth during what they described as a period of elevated utilization across the industry. Chief Executive Offi